BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22350865)

  • 21. Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma.
    Wani S; Falk G; Hall M; Gaddam S; Wang A; Gupta N; Singh M; Singh V; Chuang KY; Boolchand V; Gavini H; Kuczynski J; Sud P; Reddymasu S; Bansal A; Rastogi A; Mathur SC; Young P; Cash B; Lieberman DA; Sampliner RE; Sharma P
    Clin Gastroenterol Hepatol; 2011 Mar; 9(3):220-7; quiz e26. PubMed ID: 21115133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction.
    Ielpo B; Pernaute AS; Elia S; Buonomo OC; Valladares LD; Aguirre EP; Petrella G; Garcia AT
    Interact Cardiovasc Thorac Surg; 2010 May; 10(5):704-8. PubMed ID: 20154347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study.
    Sikkema M; Looman CW; Steyerberg EW; Kerkhof M; Kastelein F; van Dekken H; van Vuuren AJ; Bode WA; van der Valk H; Ouwendijk RJ; Giard R; Lesterhuis W; Heinhuis R; Klinkenberg EC; Meijer GA; ter Borg F; Arends JW; Kolkman JJ; van Baarlen J; de Vries RA; Mulder AH; van Tilburg AJ; Offerhaus GJ; ten Kate FJ; Kusters JG; Kuipers EJ; Siersema PD
    Am J Gastroenterol; 2011 Jul; 106(7):1231-8. PubMed ID: 21577245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population-based esophageal cancer survival after resection without neoadjuvant therapy: an update.
    Rutegård M; Charonis K; Lu Y; Lagergren P; Lagergren J; Rouvelas I
    Surgery; 2012 Nov; 152(5):903-10. PubMed ID: 22657730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
    Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
    Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Individualized surgical strategies for cancer of the esophagogastric junction.
    Stein HJ; Feith M; Siewert JR
    Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical complications and long-term survival after esophagectomy for cancer in a nationwide Swedish cohort study.
    Rutegård M; Lagergren P; Rouvelas I; Mason R; Lagergren J
    Eur J Surg Oncol; 2012 Jul; 38(7):555-61. PubMed ID: 22483704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastroesophageal junction adenocarcinoma: what are the factors influencing long-term survival?
    del Genio A; Rossetti G; Maffettone V; Napolitano V; Brusciano L; del Genio G; Russo G; Limongelli P; Fiume I; Pizza F; Tolone S; Di Martino M
    Int Surg; 2006; 91(3):174-80. PubMed ID: 16845860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancers of the esophagus and carbonated beverage consumption: a population-based case-control study.
    Ibiebele TI; Hughes MC; O'Rourke P; Webb PM; Whiteman DC;
    Cancer Causes Control; 2008 Aug; 19(6):577-84. PubMed ID: 18231869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Limited surgical resection versus local endoscopic therapy of early cancers of the esophagogastric junction].
    von Rahden BH; Feith M; Stein HJ
    Zentralbl Chir; 2006 Apr; 131(2):97-104. PubMed ID: 16612774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoscopic ultrasound predicts outcomes for patients with adenocarcinoma of the gastroesophageal junction.
    Barbour AP; Rizk NP; Gerdes H; Bains MS; Rusch VW; Brennan MF; Coit DG
    J Am Coll Surg; 2007 Oct; 205(4):593-601. PubMed ID: 17903735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of prediagnosis endoscopy with stage and survival in adenocarcinoma of the esophagus and gastric cardia.
    Cooper GS; Yuan Z; Chak A; Rimm AA
    Cancer; 2002 Jul; 95(1):32-8. PubMed ID: 12115314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
    Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
    Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
    Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cancer of the esophagus and gastroesophageal junction: evolution of surgical management].
    Triboulet JP; Piessen G; Bot J; Mariette C
    Bull Acad Natl Med; 2011 Jan; 195(1):93-112. PubMed ID: 22039706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease.
    Stiles BM; Mirza F; Coppolino A; Port JL; Lee PC; Paul S; Altorki NK
    Ann Thorac Surg; 2011 Aug; 92(2):491-6; discussion 496-8. PubMed ID: 21704291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers.
    Whiteman DC; Parmar P; Fahey P; Moore SP; Stark M; Zhao ZZ; Montgomery GW; Green AC; Hayward NK; Webb PM;
    Gastroenterology; 2010 Jul; 139(1):73-83; quiz e11-2. PubMed ID: 20399210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.
    Rindi G; Falconi M; Klersy C; Albarello L; Boninsegna L; Buchler MW; Capella C; Caplin M; Couvelard A; Doglioni C; Delle Fave G; Fischer L; Fusai G; de Herder WW; Jann H; Komminoth P; de Krijger RR; La Rosa S; Luong TV; Pape U; Perren A; Ruszniewski P; Scarpa A; Schmitt A; Solcia E; Wiedenmann B
    J Natl Cancer Inst; 2012 May; 104(10):764-77. PubMed ID: 22525418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.
    Dabaja BS; Suki D; Pro B; Bonnen M; Ajani J
    Cancer; 2004 Aug; 101(3):518-26. PubMed ID: 15274064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.